Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3825989 | 0.86 | HSP90AA1 (0.40) | HSP90AA1CYP3A4TSHRALDH1A1TP53 | |
| SCHEMBL3824917 | 0.80 | SMN1; SMN2 (0.39) | CYP3A4TSHRALDH1A1TP53ALOX15 | |
| SCHEMBL3819722 | 0.78 | HSP90AA1 (0.38) | HSP90AA1CYP3A4TSHRALDH1A1TP53 | |
| SCHEMBL3820152 | 0.74 | ALDH1A1 (0.33) | HSP90AA1CYP3A4TSHRALDH1A1TP53 | |
| SCHEMBL3825196 | 0.71 | RXRA (0.35) | HSP90AA1CYP3A4TSHRALDH1A1TP53 | |
| SCHEMBL3824912 | 0.68 | SMN1; SMN2 (0.47) | CYP3A4TSHRALDH1A1TP53ALOX15 | |
| SCHEMBL241470 | 0.67 | HSP90AA1 (0.62) | HSP90AA1CYP3A4TSHRALDH1A1ALOX15 | |
| SCHEMBL29671062 | 0.67 | HSP90AA1 (0.62) | HSP90AA1CYP3A4TSHRALDH1A1ALOX15 | |
| SCHEMBL29370116 | 0.67 | HSP90AA1 (0.62) | HSP90AA1CYP3A4TSHRALDH1A1ALOX15 | |
| SCHEMBL1490760 | 0.67 | HSP90AA1 (0.54) | HSP90AA1CYP3A4TSHRALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1406726-B1 | ORGANOALUMINIUM CATALYST, ITS PREPARATION AND ITS USE IN A PROCESS FOR THE POLYMERIZATION OF ALKYLENE OXIDES | UNION CARBIDE CHEM PLASTIC (US) | 2009-08-26 | — | — | EP | disclosed |
| US-7456127-B2 | Organoaluminum catalyst | UNION CARBIDE CHEMICALS AND PLASTICS TECHNOLOGY CORPORATION | 2008-11-25 | — | — | US | disclosed |
| US-20040142814-A1 | Organoaluminum catalyst | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC | 2004-07-22 | — | — | US | disclosed |
| EP-1406726-A2 | ORGANOALUMINIUM CATALYST, ITS PREPARATION AND ITS USE IN A PROCESS FOR THE POLYMERIZATION OF ALKYLENE OXIDES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2004-04-14 | — | — | EP | disclosed |
| WO-2002098559-A2 | ORGANOALUMINUM CATALYST, ITS PREPARATION AND ITS USE IN A PROCESS FOR THE POLYMERIZATION OF ALKYLENE OXIDES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY COR PORATION (US) | 2002-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142814-A1 | Organoaluminum catalyst | AHR, LBR, NR1H3 | HSP90AA1 2574/4885CYP3A4 247/4885TSHR 92/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.